Data from DELIVER and ACHIEVE Clinicals Trial to be Presented -- Presentation on ACHIEVE Trial in DM1 and Company Symposium to Feature Data on ...

A nutritional scientist has spoken about a ‘superfood’ which costs 30p each which can reducing inflammation and lowering ...

Moderna (MRNA) said that the two-season Phase 3 study evaluating the efficacy, safety and immunogenicity of Moderna’s trivalent vaccine against ...

Four years after receiving Hemgenix in a Phase 3 trial, bleeding rates and the use of replacement therapy are low for men ...

The gender health gap is real. Although women have a longer life expectancy than men, they often experience worse health ...

Eko Health developed an AI algorithm that, combined with noninvasive heart tests, may be able to accurately identify pulmonary hypertension.

NHS Ayrshire and Arran is facing "significant pressures" after figures revealed that more than a third of patients waited ...

The Janus Henderson Global Sustainable Equity Fund returned -5.88% for Q4 2024. Click here to read the full commentary.

Over a decade spent treating and researching substance use disorders taught one researcher that the overdose epidemic is a ...

ICON Public Limited (NASDAQ:ICLR – Get Free Report)’s share price reached a new 52-week low on Thursday after Truist Financial lowered their price target on the stock from $284.00 to $262.00. Truist ...

Campaigners say children in study would be ‘treated worse than guinea pigs’ because drugs’ harms are well known ...

New drugs for early Alzheimer’s disease may allow people to live without help for up to 39 additional months, a new study ...